Comparable stake leader
BAKER BROS. ADVISORS LP
SEC ownership of Replimune Group, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001737953.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
11 Aug 2026
- Public ticker
- REPL on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BAKER BROS. ADVISORS LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BAKER BROS. ADVISORS LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
11 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001737953
- Issuer location
- Woburn, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Replimune Group, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAKER BROS. ADVISORS LP
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
11 Aug 2026
3/4/5
13D/G
13F
Lead comparable stake: 12%
13D/G row: BAKER BROS. ADVISORS LP
Showing 1-8 of 50 holder rows.
Quick read
BAKER BROS. ADVISORS LP leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAKER BROS. ADVISORS LP's linked filing trail.
Comparable ownership
Top 5
BAKER BROS. ADVISORS LP
12%
RTW INVESTMENTS, LP
8.9%
Ridgeback Capital Investments L.P.
8.7%
MONTANOVA CAPITAL, LLC
7.9%
GOLDMAN SACHS GROUP INC
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
3/4/5
13D/G
13F
Director, 10%+ Owner · Company
|
12%
from 13D/G
|
$157,117,587
12,770,541 shares
mixed-class rows
|
+$32,999,987 | 11 Aug 2026 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
8.9%
from 13D/G
|
$82,046,202
7,411,581 shares
|
— | 30 Jun 2026 |
| Ridgeback Capital Investments L.P. |
13D/G
13F
Company
|
8.7%
|
$81,294,495
7,310,656 shares
|
+$11,765,016 | 30 Jun 2026 |
| MONTANOVA CAPITAL, LLC |
13D/G
13F
Company
|
7.9%
|
$73,492,080
6,609,000 shares
|
+$26,545,264 | 30 Jul 2026 |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
|
5.3%
from 13D/G
|
$50,269,070
4,541,018 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.3%
|
$49,374,401
4,440,144 shares
|
$0 | 30 Jun 2026 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.8%
|
$32,542,424
3,595,848 shares
|
$0 | 31 Dec 2024 |
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
4.7%
|
$15,209,289
3,629,902 shares
|
-$3,488,586 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$196,066,858.
Buys
$197,999,921
Insiders: 6
Sells
$1,933,063
Insiders: 7
Net
+$196,066,858
Shares: +16,201,455
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 16,418,040
Shares: 216,585
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 16,418,040 | 91,124 | $197,999,921 | $1,149,244 | +$196,850,677 |
| 3-6 | 0 | 99,836 | $0 | $526,212 | -$526,212 |
| 6-9 | 0 | 13,169 | $0 | $144,258 | -$144,258 |
| 9-12 | 0 | 12,456 | $0 | $113,350 | -$113,350 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 29 reporting-owner rows connected to Replimune Group, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
29
Largest Forms 3/4/5 holder
BAKER BROS. ADVISORS LP
Net 12M change
+$196,066,858
Latest report
20 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $157,117,587 | +$32,999,987 | +27% | Mixed | 11 Aug 2026 |
| Omega Fund IV, L.P. | 10%+ Owner | $103,049,420 | Mixed | 14 Mar 2022 | ||
| Baker Bros. Advisors (GP) LLC | Director, 10%+ Owner | $31,475,687 | +$32,999,987 | +105% | Filing P/S | 11 Aug 2026 |
| Baker Brothers Life Sciences LP | Director, 10%+ Owner | $31,475,687 | +$32,999,987 | +105% | Filing P/S | 11 Aug 2026 |
| 667, L.P. | Director, 10%+ Owner | $31,475,687 | +$32,999,987 | +105% | Filing P/S | 11 Aug 2026 |
| Julian C. Baker | Director, 10%+ Owner | $31,475,687 | +$32,999,987 | +105% | Filing P/S | 11 Aug 2026 |
| Felix Baker | Director, 10%+ Owner | $31,475,687 | +$32,999,987 | +105% | Filing P/S | 11 Aug 2026 |
| Philip Astley-Sparke | Director | $15,081,922 | -$89,698 | -0.59% | Median | 20 Aug 2026 |
| Robert Coffin | Director | $11,787,512 | Filing P/S | 16 May 2024 | ||
| Sushil Patel | Chief Executive Officer, Director | $9,184,718 | -$811,159 | -8.1% | Filing P/S | 10 Aug 2026 |
| Colin Love | Chief Operating Officer | $5,029,422 | Filing P/S | 16 May 2024 | ||
| Emily Luisa Hill | Chief Financial Officer | $3,082,366 | -$320,341 | -9.4% | Filing P/S | 17 Aug 2026 |
| Konstantinos Xynos | Chief Medical Officer | $2,908,068 | -$285,661 | -8.9% | Filing P/S | 10 Aug 2026 |
| Pamela Esposito | Chief Business Officer | $2,876,721 | Mixed | 11 Sep 2023 | ||
| Christopher Sarchi | Chief Commercial Officer | $1,672,088 | -$254,158 | -13% | Filing P/S | 01 Jun 2026 |
| Tanya Lewis | Chief Dev. Op. Officer | $1,477,400 | Mixed | 13 Jun 2023 | ||
| Jean M. Franchi | Chief Financial Officer | $1,405,928 | Mixed | 16 May 2023 | ||
| Andrew Schwendenman | Chief Accounting Officer | $1,289,542 | -$139,089 | -9.7% | Filing P/S | 10 Aug 2026 |
| Kapil Dhingra | Director | $0 | -$32,958 | -100% | Mixed | 01 Apr 2026 |
| Paolo Pucci | Director | Mixed | 01 Apr 2026 |
Recent insider transactions for Replimune Group, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Philip Astley-Sparke | REPL | Common Stock | Gift | -3.54% | -50,000 | 1,362,414 | 20 Aug 2026 | Direct | ||
| Emily Luisa Hill | REPL | Common Stock | Sale | -4.11% | $132,176 | $14.28 | -9,256 | 215,852 | 17 Aug 2026 | Direct |
| BAKER BROS. ADVISORS LP | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| BAKER BROS. ADVISORS LP | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| Baker Bros. Advisors Lp | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| Baker Bros. Advisors Lp | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| Baker Bros. Advisors Lp | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| Baker Bros. Advisors Lp | REPL | 2026 $0.0001 Prefunded Warrants | Purchase | $32,999,987 | $12.06 | 2,736,340 | 2,609,946 | 11 Aug 2026 | See Footnotes | |
| Sushil Patel | REPL | Common Stock | Sale | -5.26% | $510,253 | $12.97 | -39,341 | 708,151 | 10 Aug 2026 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -4.84% | $148,481 | $12.97 | -11,448 | 225,108 | 10 Aug 2026 | Direct |
| Konstantinos Xynos | REPL | Common Stock | Sale | -4.86% | $148,468 | $12.97 | -11,447 | 224,215 | 10 Aug 2026 | Direct |
| Andrew Schwendenman | REPL | Common Stock | Sale | -7.13% | $98,987 | $12.97 | -7,632 | 99,425 | 10 Aug 2026 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -6.22% | $110,880 | $9.24 | -12,000 | 180,962 | 01 Jun 2026 | Direct |
| Konstantinos Xynos | REPL | Common Stock | Sale | -5.62% | $71,237 | $5.08 | -14,023 | 235,662 | 18 May 2026 | Direct |
| Andrew Schwendenman | REPL | Common Stock | Sale | -6.87% | $40,102 | $5.08 | -7,894 | 107,057 | 18 May 2026 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.28% | $43,820 | $5.08 | -8,626 | 192,962 | 18 May 2026 | Direct |
| Philip Astley-Sparke | REPL | Common Stock | Sale | -1.23% | $89,698 | $5.08 | -17,657 | 1,412,414 | 18 May 2026 | Direct |
| Sushil Patel | REPL | Common Stock | Sale | -4.76% | $189,606 | $5.08 | -37,324 | 747,492 | 18 May 2026 | Direct |
| Emily Luisa Hill | REPL | Common Stock | Sale | -3.2% | $39,685 | $5.08 | -7,812 | 236,556 | 18 May 2026 | Direct |
| Christopher Sarchi | REPL | Common Stock | Sale | -4.11% | $52,065 | $8.01 | -6,500 | 151,588 | 02 Apr 2026 | Direct |
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| BAKER BROS. ADVISORS LP | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Baker Bros. Advisors Lp | REPL | Non-Qualified Stock Option (right to buy)uy) | Award | 89,000 | 44,500 | 01 Apr 2026 | See Footnotes | |||
| Christopher Sarchi | REPL | Common Stock | Award | 33% | 50,000 | 201,588 | 01 Apr 2026 | Direct | ||
| Christopher Sarchi | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Award | 3.62% | 50,000 | 1,430,071 | 01 Apr 2026 | Direct | ||
| Philip Astley-Sparke | REPL | Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Christy J. Oliger | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Konstantinos Xynos | REPL | Common Stock | Award | 25% | 50,000 | 249,685 | 01 Apr 2026 | Direct | ||
| Konstantinos Xynos | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Madhavan Balachandran | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Andrew Schwendenman | REPL | Common Stock | Award | -24.2% | -36,667 | 114,951 | 01 Apr 2026 | Direct | ||
| Andrew Schwendenman | REPL | Employee Stock Option (right to buy) | Award | 55,000 | 55,000 | 01 Apr 2026 | Direct | |||
| Sushil Patel | REPL | Common Stock | Award | 47.1% | 251,240 | 784,816 | 01 Apr 2026 | Direct | ||
| Sushil Patel | REPL | Employee Stock Option (right to buy) | Award | 376,860 | 376,860 | 01 Apr 2026 | Direct | |||
| Kapil Dhingra | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Paolo Pucci | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Joseph P. Slattery | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Veleka Peeples-Dyer | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Emily Luisa Hill | REPL | Common Stock | Award | 25.7% | 50,000 | 244,368 | 01 Apr 2026 | Direct | ||
| Emily Luisa Hill | REPL | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 01 Apr 2026 | Direct | |||
| Dieter Weinand | REPL | Stock Option (right to buy) | Award | 44,500 | 44,500 | 01 Apr 2026 | Direct | |||
| Philip Astley-Sparke | REPL | Common Stock | Gift | -1.78% | -25,000 | 1,380,071 | 18 Feb 2026 | Direct | ||
| Sushil Patel | REPL | Common Stock | Award | 60% | 200,000 | 533,576 | 19 Dec 2025 | Direct | ||
| Konstantinos Xynos | REPL | Common Stock | Award | 43% | 60,000 | 199,685 | 19 Dec 2025 | Direct | ||
| Emily Luisa Hill | REPL | Common Stock | Award | 44.6% | 60,000 | 194,368 | 19 Dec 2025 | Direct | ||
| Christopher Sarchi | REPL | Common Stock | Award | 28.4% | 35,000 | 158,088 | 19 Dec 2025 | Direct |
* marks a reported price that did not pass the local price check.